Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
Limit the Variables

Oct 1, 2019/Column

A research staple has much wider applicability.

Professional Decision Making on the Line

Feb 1, 2022/Column

Every practice setting has its challenges and special circumstances, but they all share professional expectations and responsibilities.

New Study Reimagines the Relationship Between Daily Steps and Health Outcomes

Sep 3, 2025/Article

For decades, 10,000 steps a day has been regarded as a near-universal benchmark for fitness and general health goals — often promoted by wearable fitness trackers and public health campaigns. However, an August 2025 study, "Daily steps and health outcomes in adults: a systematic review and dose-response

Get to Know APTA Home Health: An Interview With Academy President Philip Goldsmith

Dec 10, 2024/Podcast

A brief introduction from the president of the academy.

Foundation for Physical Therapy Research to Open Scholarship Applications Oct. 4

Sep 22, 2023/News

The program supports post-professional doctoral students both prior to and post-candidacy.

Melissa Hofmann, PT, PhD

Jun 30, 2020/Author

Melissa C. Hofmann, PT, PhD, is co-chair of PT Proud and faculty at Regis University in the Physical Therapy Department. You can connect with Melissa on Twitter at @melhofmann.

Karla A. Bell, PT, DPT

Jun 30, 2020/Author

Karla A. Bell, PT, DPT, is co-chair of PT Proud and faculty at Thomas Jefferson University in the Physical Therapy Department. You can connect with Karla on Twitter at @passionatept.

What Is PTPAC? Five Things You Need to Know

Feb 3, 2023/News

Our political action committee is working on issues that matter now and into the profession's future.

New Member Benefit a One-Stop-Shop for Prior Authorization, UM Advocacy Tools

Mar 15, 2022/News

APTA and the Private Practice Section have collaborated to create SPARC — the State Payer Advocacy Resource Center.

Rivermead Mobility Index for Multiple Sclerosis (MS)

Sep 12, 2013/Test & Measure

Target population: People with multiple sclerosis (MS).